About Daniel Browne
Daniel Browne is a director at Avava.
Daniel Browne first appears on SEC filings in 2024.
Experience
This experience comes from Daniel Browne's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Browne in the role, so the role may have started earlier or lasted longer.
TI
Tasman Therapeutics, Inc. Current
President & CEO
2025 – Present
FI
Fount Bio, Inc. Current
Director Board of Directors
2021 – Present
Avava, Inc. Current
Director Board of Directors
2020 – Present · Waltham, MA
AVAVA makes laser devices for skin treatments.
GA
Galderma Current
Director Board of Directors
2020 – Present
LD
Lieber Institute for Brain Development
Director Board of Directors
2025 – 2026
RT
Revance Therapeutics
Co-Founder & President & CEO
2002 – 2019
NE
Neomend
President & CEO
2000 – 2002
PM
PROGRAFT MEDICAL
President & CEO
1997 – 1999
WA
W. L. Gore & Associates
Business Leader, Interventional Products
1984 – 1997
Key Colleagues at Startups
The people Daniel Browne works with at each company, as listed on that company's latest Form D.
Avava, Inc. · Form D, Mar 4, 2026
CJ
Clinton Carnell Jr.
Chief Executive Officer and director
MF
Mary Fisher
Director
JB
Jay Bhawalkar
Executive officer
RA
Richard Anderson
Director